ANIP ANI Pharmaceuticals Inc.

ANI Pharmaceuticals to Present at the Jefferies Global Healthcare Conference – London

ANI Pharmaceuticals to Present at the Jefferies Global Healthcare Conference – London

PRINCETON, N.J., Nov. 11, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that Nikhil Lalwani, Chief Executive Officer, will participate in a fireside chat at the Jefferies Global Healthcare Conference – London on Tuesday, November 18, at 3:00 p.m. GMT/10:00 a.m. ET.

The live and archived fireside chat will be accessible from the Company’s website at , under the Investors section under Events and Presentations. The replay of the webcast will be accessible for 90 days.

About ANI

ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) is a diversified biopharmaceutical company committed to its mission of “Serving Patients, Improving Lives" by developing, manufacturing, and commercializing innovative and high-quality therapeutics. The Company is focused on delivering sustainable growth through its Rare Disease business, which markets novel products in the areas of ophthalmology, rheumatology, nephrology, neurology, and pulmonology; its Generics business, which leverages R&D expertise, operational excellence, and U.S.-based manufacturing; and its Brands business. For more information, visit .

Investor Relations:

Courtney Mogerley, Argot Partners

T: 646-368-8014

E:



EN
11/11/2025

Underlying

ANIPANI Pharmaceuticals Inc.

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on ANI Pharmaceuticals Inc.

 PRESS RELEASE
Free
ANIP ANI Pharmaceuti...

ANI Pharmaceuticals Announces Formation of “FutureVision Advisory Coun...

ANI Pharmaceuticals Announces Formation of “FutureVision Advisory Council” to Help Strategically Guide Ophthalmology and Retina Franchise Expert retina and uveitis specialists will help support the growth and innovation of ANI’s ophthalmology and retina franchise for a meaningful impact on patients PRINCETON, N.J., Dec. 02, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (Nasdaq: ANIP) today announced that it has established The FutureVision Advisory Council to help guide the strategic advancement of its ophthalmology and retina franchise within the Company’s...

December 2, 2025 1 EN
 PRESS RELEASE
Free
ANIP ANI Pharmaceuti...

ANI Pharmaceuticals Announces Board Transition

ANI Pharmaceuticals Announces Board Transition Patrick D. Walsh steps down as Chairman and will complete his current term as Board memberThomas J. Haughey has been unanimously elected to serve as the next Chairman of the Board PRINCETON, N.J., Dec. 01, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (Nasdaq: ANIP) today announced that its Chairman, Patrick D. Walsh, will retire from the Company's Board of Directors after a distinguished tenure of service. His retirement will be effective after completing his current term through the Company’s 2026 Annual Meet...

December 1, 2025 1 EN
 PRESS RELEASE
Free
ANIP ANI Pharmaceuti...

ANI Pharmaceuticals to Present at the Piper Sandler 37th Annual Health...

ANI Pharmaceuticals to Present at the Piper Sandler 37th Annual Healthcare Conference PRINCETON, N.J., Nov. 25, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that Nikhil Lalwani, Chief Executive Officer, will participate in a fireside chat at the Piper Sandler 37th Annual Healthcare Conference on Tuesday, December 2, at 2:00 p.m. ET. The live and archived fireside chat will be accessible from the Company’s website at , under the Investors section under Events and Presentations. The replay of the webcast will be accessible for 90 da...

November 25, 2025 1 EN
Free Trial
ANIP ANI Pharmaceuti...

ANI Pharmaceuticals Inc: 1 director

A director at ANI Pharmaceuticals Inc sold/gave away 11,643 shares at 0.000USD and the significance rating of the trade was 71/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last ...

ANIP ANI PHARMACEUTICALS INC.
11/18/25 November 18, 2025 1 EN
 PRESS RELEASE
Free
ANIP ANI Pharmaceuti...

ANI Pharmaceuticals to Present at the Jefferies Global Healthcare Conf...

ANI Pharmaceuticals to Present at the Jefferies Global Healthcare Conference – London PRINCETON, N.J., Nov. 11, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that Nikhil Lalwani, Chief Executive Officer, will participate in a fireside chat at the Jefferies Global Healthcare Conference – London on Tuesday, November 18, at 3:00 p.m. GMT/10:00 a.m. ET. The live and archived fireside chat will be accessible from the Company’s website at , under the Investors section under Events and Presentations. The replay of the webcast will be acce...

November 11, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch